Gebeyaw Mekonnen, a 53-year-old patient, faced a dire diagnosis of lung cancer. Initially diagnosed without a PET-CT scan, he underwent surgery and six rounds of chemotherapy. However, a few months later, he began exhibiting symptoms such as coughing up blood. By then, the cancer had spread to both of his lungs, and his local doctor advised him to seek palliative care.
Desperate for a more hopeful solution, Gebeyaw turned to Manaaki Healthcare. We facilitated his travel to BLK-MAX Hospital in India for a biopsy and PET-CT scan. Under the care of Dr. Dabas, Gebeyaw received his first round of chemotherapy and was impressed with the level of care. It was determined that chemotherapy and radiation alone would not suffice; instead, molecular testing was needed to identify the specific type of cancer and the appropriate medication.
The results revealed that Gebeyaw’s form of cancer could be treated with targeted therapy, a treatment lasting three months. Manaaki Healthcare’s staff in India even secured a discount for his treatment.
After three months of targeted therapy, Gebeyaw returned to India and was overjoyed to learn that 90% of the cancer had disappeared. He returned to Ethiopia on March 21 and will need regular checkups. To ensure his continued recovery, Manaaki Healthcare provides monthly reports to his doctors, ensuring that he remains healthy and the follow-up treatment is effective.
Gebeyaw’s story underscores the vital role of Manaaki Healthcare in providing exceptional care and support, significantly contributing to his remarkable recovery.
